Table 2.
Procedural Characteristics
| Characteristic | ViTAVR (N=25) | ViSAVR (N=74) | P Value (Overall) | N |
|---|---|---|---|---|
| Time since index procedure, y | <0.001 | 55 | ||
| <5 | 18 (72.0) | 5 (16.7) | ||
| 5–10 | 7 (28.0) | 10 (33.3) | ||
| >10 | 0 (0.00) | 15 (50.0) | ||
| Indication for ViV | 0.754 | 99 | ||
| AR | 4 (16.0) | 8 (10.8) | ||
| AS | 14 (56.0) | 44 (59.5) | ||
| Combined | 7 (28.0) | 22 (29.7) | ||
| ViV access | 0.455 | 98 | ||
| Transapical | 4 (16.7) | 7 (9.46) | ||
| Transfemoral | 20 (83.3) | 67 (90.5) | ||
| ViV predilation | <0.001 | 99 | ||
| No | 15 (60.0) | 73 (98.6) | ||
| Yes | 10 (40.0) | 1 (1.35) | ||
| ViV device | 0.226 | 99 | ||
| CoreValve | 7 (28.0) | 12 (16.2) | ||
| CoreValve Evolut R | 3 (12.0) | 3 (4.05) | ||
| Portico | 0 (0.00) | 2 (2.70) | ||
| Sapien | 3 (12.0) | 17 (23.0) | ||
| Sapien XT | 3 (12.0) | 19 (25.7) | ||
| Sapien3 | 9 (36.0) | 21 (28.4) | ||
| ViV device self‐expandable | 0.164 | 99 | ||
| Yes | 10 (40.0) | 17 (23.0) | ||
| No | 15 (60.0) | 57 (77.0) | ||
| ViV size, mm | 26.0 (26.0–26.0) | 23.0 (23.0–26.0) | <0.001 | 99 |
| Postdilatation | 0.547 | 98 | ||
| No | 16 (66.7) | 56 (75.7) | ||
| Yes | 8 (33.3) | 18 (24.3) | ||
| Postprocedural gradient, mm Hg | 0.349 | 95 | ||
| <20 | 19 (79.2) | 47 (66.2) | ||
| >19 | 5 (20.8) | 24 (33.8) | ||
| Post‐ViV PVL > mild | 0.570 | 97 | ||
| No | 25 (100) | 68 (94.4) | ||
| Yes | 0 (0.00) | 4 (5.56) | ||
| Device success | 0.415 | 95 | ||
| Accomplished | 19 (79.2) | 48 (67.6) | ||
| Not accomplished | 5 (20.8) | 23 (32.4) |
Values are shown as median (interquartile range) for continuous variables and number (percentage) for categorical variables. Group differences are presented as overall P value. AR indicates aortic regurgitation; AS, aortic stenosis; PVL, paravalvular leakage; ViSAVR, valve in surgical aortic valve replacement; ViTAVR, valve in transcatheter aortic valve replacement; and ViV, valve‐in‐valve.